CANNABIDEX Trademark

Trademark Overview


On Thursday, December 20, 2018, a trademark application was filed for CANNABIDEX with the United States Patent and Trademark Office. The USPTO has given the CANNABIDEX trademark a serial number of 88176634. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 23, 2022. This trademark is owned by GW Research Limited. The CANNABIDEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no ...
cannabidex

General Information


Serial Number88176634
Word MarkCANNABIDEX
Filing DateThursday, December 20, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal herbs, medicinal oils, pure extracts of medicinal plants and herbs for pharmaceutical use, dietetic foodstuffs specially adapted for medicinal purposes, herb teas for medicinal purposes, none of the foregoing herbs, oils, extracts, foodstuffs, or teas comprised of Cannabis sativa L or any oils, extracts, ingredients or derivatives thereof with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 15, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Research Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCambridge CB249BZ
GB

Party NameGW Research Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCambridge CB249BZ
GB

Trademark Events


Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 19, 2021SOU EXTENSION 3 FILED
Tuesday, October 19, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 2 GRANTED
Thursday, April 15, 2021SOU EXTENSION 2 FILED
Thursday, April 15, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 1, 2020SOU EXTENSION 1 FILED
Tuesday, September 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020ASSIGNED TO LIE
Friday, January 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION WRITTEN
Monday, June 24, 2019ASSIGNED TO EXAMINER
Monday, November 19, 2018ASSIGNED TO EXAMINER
Thursday, November 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 3, 2018NEW APPLICATION ENTERED